Lanean...
Antibody-Based Immunotherapeutic Strategies for the Treatment of Hematological Malignancies
As the most common type of cancer in the world, hematological malignancies (HM) account for 10% of all annual cancer deaths and have attracted more attention. Conventional treatments, such as chemotherapy, radiotherapy, and hematopoietic stem cell transplantation (HSCT), could relieve patients suffe...
Gorde:
| Argitaratua izan da: | Biomed Res Int |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Hindawi
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7519992/ https://ncbi.nlm.nih.gov/pubmed/33015169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/4956946 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|